{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:02:47Z","timestamp":1790726567151,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":221,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02725","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:11:08Z","timestamp":1787155868000},"page":"e02725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A case of prolonged cefiderocol therapy during continuous hemodiafiltration in a patient with an implanted left ventricular assist device"],"prefix":"10.1016","volume":"45","author":[{"given":"Hiroshi","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiro","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisamichi","family":"Tauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idcr.2026.e02725_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-023-01146-5","article-title":"Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence","volume":"13","author":"Viale","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02725_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1473-3099(20)30731-3","article-title":"Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial","volume":"21","author":"Wunderink","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02725_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02725_bib4","unstructured":"U.S. Food and Drug Administration. FETROJA (cefiderocol) for injection, for intravenous use: prescribing information. 2020."},{"issue":"4","key":"10.1016\/j.idcr.2026.e02725_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40262-021-01086-y","article-title":"Pharmacokinetics, pharmacodynamics, and dose optimization of cefiderocol during continuous renal replacement therapy","volume":"61","author":"Wenzler","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.idcr.2026.e02725_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.784208","article-title":"Driveline features as risk factor for infection in left ventricular assist devices: meta-analysis and experimental tests","volume":"8","author":"Kranzl","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.idcr.2026.e02725_bib7","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. CLSI supplement M100. 35th ed. CLSI M100ED35. Wayne, PA: CLSI; 2025."},{"issue":"10","key":"10.1016\/j.idcr.2026.e02725_bib8","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.healun.2017.06.007","article-title":"An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection","volume":"36","author":"Kusne","year":"2017","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02725_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ejcts\/ezz098","article-title":"2019 EACTS Expert Consensus on long-term mechanical circulatory support","volume":"56","author":"Potapov","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"10.1016\/j.idcr.2026.e02725_bib10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/cpt.2703","article-title":"Cefiderocol dosing for patients receiving continuous renal replacement therapy","volume":"112","author":"Wei","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.idcr.2026.e02725_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab252","article-title":"Cefiderocol pharmacokinetics in a patient receiving continuous venovenous hemodiafiltration","volume":"8","author":"Kobic","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02725_bib12","article-title":"A new dosing frontier: retrospective assessment of effluent flow rates and residual renal function among critically Ill patients receiving continuous renal replacement therapy","volume":"6","author":"Lakshmipathy","year":"2024","journal-title":"Crit Care Explor"},{"issue":"10","key":"10.1016\/j.idcr.2026.e02725_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae451","article-title":"Validation of cefiderocol package insert dosing recommendation for patients receiving continuous renal replacement therapy: a prospective multicenter pharmacokinetic study","volume":"11","author":"Fouad","year":"2024","journal-title":"Open Forum Infect Dis"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:14:07Z","timestamp":1790723647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250926002386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":13,"alternative-id":["S2214250926002386"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02725","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of prolonged cefiderocol therapy during continuous hemodiafiltration in a patient with an implanted left ventricular assist device","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02725"}}